BioCentury
ARTICLE | Clinical News

Lotrel amlodipine/benazepril: Additional Phase III data

February 22, 2010 8:00 AM UTC

Additional data from the double-blind, U.S. and Scandinavian Phase III ACCOMPLISH trial in 11,506 patients showed that Lotrel led to significantly less progression of CKD vs. benazepril plus hydrochlo...